What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
His primary areas of investigation include Alzheimer's disease, Cerebrospinal fluid, Pathology, Dementia and Internal medicine.
His Alzheimer's disease study combines topics from a wide range of disciplines, such as Apolipoprotein E and Gerontology.
Juan Fortea combines subjects such as Neurodegeneration, Disease, Pathophysiology, Biomarker and Neurology with his study of Cerebrospinal fluid.
His biological study spans a wide range of topics, including Precuneus and Neuroimaging.
Frontotemporal dementia is the focus of his Dementia research.
His work deals with themes such as Oncology and Cardiology, which intersect with Internal medicine.
His most cited work include:
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (429 citations)
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. (402 citations)
- Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. (324 citations)
What are the main themes of his work throughout his whole career to date?
Juan Fortea mostly deals with Disease, Cerebrospinal fluid, Dementia, Pathology and Internal medicine.
He interconnects Down syndrome, Neuroscience and Bioinformatics in the investigation of issues within Disease.
His research on Cerebrospinal fluid also deals with topics like
- Biomarker that intertwine with fields like Gastroenterology,
- Neurodegeneration that intertwine with fields like TREM2.
His work on Cognitive decline as part of general Dementia research is frequently linked to Genetic association, thereby connecting diverse disciplines of science.
The concepts of his Pathology study are interwoven with issues in Inflammation and Magnetic resonance imaging.
His Alzheimer's disease course of study focuses on Minor allele frequency and Case-control study.
He most often published in these fields:
- Disease (40.34%)
- Cerebrospinal fluid (31.76%)
- Dementia (31.76%)
What were the highlights of his more recent work (between 2019-2021)?
- Down syndrome (21.89%)
- Disease (40.34%)
- Neuroscience (18.45%)
In recent papers he was focusing on the following fields of study:
Juan Fortea focuses on Down syndrome, Disease, Neuroscience, Neuroimaging and Cerebrospinal fluid.
His Down syndrome research is multidisciplinary, incorporating elements of Life expectancy, Pediatrics and Cohort, Pathology.
His research integrates issues of Clinical psychology and Bioinformatics in his study of Disease.
He has researched Neuroimaging in several fields, including Alzheimer's disease, Disease progression, Magnetic resonance imaging and In vivo.
His Cerebrospinal fluid research is included under the broader classification of Internal medicine.
His Dementia study combines topics in areas such as Cognitive test and Amyloid.
Between 2019 and 2021, his most popular works were:
- Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. (19 citations)
- COVID-19-associated ophthalmoparesis and hypothalamic involvement. (15 citations)
- New insights on the genetic etiology of Alzheimer’s and related dementia (12 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Juan Fortea mainly investigates Dementia, Disease, Cerebrospinal fluid, Internal medicine and Down syndrome.
The various areas that he examines in his Dementia study include Genetic architecture, Life expectancy, DNA sequencing and Amyloid.
His studies deal with areas such as Gerontology and Bioinformatics as well as Disease.
His Cerebrospinal fluid study integrates concerns from other disciplines, such as Amyloid beta, Cholinergic, Degeneration, Nucleus basalis and Alzheimer's disease.
His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Asymptomatic and other disciplines.
His study looks at the relationship between Down syndrome and fields such as Biomarker, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
